multiple sclerosis: A progressive autoimmune disorder affecting the central nervous system resulting in demyelination. Patients develop physical and cognitive impairments that correspond with the affected nerve fibers.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
3069 |
4. Check minimum number of eventsNone |
3069 |
5. Include endpointsNone |
3069 |
6. Filter based on genotype QC (FinnGen only) |
3069 |
Control definitions (FinnGen only)
- Control exclude
- G6_DISSOTH, G6_OTHDEMYEL, G6_ADEM, G6_ENCEPHBACT, G6_ENCEPHOTH
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G35-G37
- Name in latin
- Sclerosis multiplex
Similar endpoints
↥List of similar endpoints to
MS-disease / Multiple Sclerosis
based on the number of shared cases.
Similar with more cases:
- Demyelinating diseases of the central nervous system
- Autoimmune diseases related-to ILD
- Autoimmune diseases
- Used for control exclusion in common control thyroid runs
- Neurological diseases
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 19836 | 13288 | 6385 |
| Only index persons | 17256 | 11971 | 5285 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.31 | 0.38 | 0.18 |
| Only index persons | 0.37 | 0.44 | 0.20 |
| Median age at first event (years) | |||
| Whole population | 39.19 | 38.69 | 40.18 |
| Only index persons | 38.41 | 38.12 | 39.08 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3069 | 2293 | 776 |
| Unadjusted period prevalence (%) | 0.67 | 0.78 | 0.34 |
| Median age at first event (years) | 37.61 | 36.63 | 40.49 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2752
- Matched controls
- 27519
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
TAB00
NOMESCO Finland
Lumbar puncture
24.3
323.0
878
521
L04AA27
ATC
fingolimod; oral
+∞
323.0
321
*
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
+∞
323.0
758
*
N04BB01
ATC
amantadine; oral
75.3
323.0
511
83
G35
ICD-10 Finland
Multiple sclerosis
4503599627370496.0
323.0
2676
*
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
+∞
323.0
1579
*
N07XX09
ATC
[U] dimethyl fumarate; oral
+∞
323.0
333
*
L03AX13
ATC
glatiramer acetate; parenteral
+∞
323.0
672
*
109
Kela drug reimbursment
Multiple sclerosis
+∞
323.0
1876
*
H46
ICD-10 Finland
Optic neuritis
308.8
323.0
694
30
L04AX07
ATC
dimethyl fumarate; oral
+∞
323.0
510
*
L03AB08
ATC
interferon beta-1b; parenteral
+∞
323.0
382
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
23.2
323.0
1299
1022
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
+∞
323.0
1503
*
164
Kela drug reimbursment
Fingolimod
+∞
323.0
438
*
L04AA31
ATC
teriflunomide; oral
+∞
323.0
408
*
L03AB07
ATC
interferon beta-1a; parenteral
+∞
323.0
867
*
353
Kela drug reimbursment
Cladribine and fingolimod
+∞
323.0
386
*
N86
ICPC
Multiple sclerosis
10262.7
323.0
762
*
M03BX01
ATC
baclofen; systemic
30.9
307.6
417
158
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
21.6
223.1
336
176
2AB04
NOMESCO Finland
NA
589.0
222.7
218
*
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
30.7
215.5
292
106
3400A
ICD-9 Finland
Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]
+∞
211.2
200
*
XKD06
NOMESCO Finland
Physiologic investigation of micturition
20.7
209.5
320
174
XA800
NOMESCO Finland
Neuropsychological investigation
11.2
209.3
418
433
F02.89*G35
ICD-10 Finland
Dementia in multiple sclerosis
+∞
191.9
182
*
XCK00
NOMESCO Finland
Perimetry
8.6
182.8
425
572
G36.9
ICD-10 Finland
Acute disseminated demyelination, unspecified
+∞
181.3
172
*
R20.2
ICD-10 Finland
Paraesthesia of skin
6.3
178.9
523
982
G04BD09
ATC
trospium; oral
18.2
170.0
271
164
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.8
167.8
532
1100
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.2
166.3
746
2228
G04BD12
ATC
mirabegron; oral
6.2
163.5
483
912
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
5.5
161.7
534
1155
XKD00
NOMESCO Finland
Uroflowmetry
5.7
159.8
510
1058
34099
ICD-8 Finland
Multiple sclerosis
+∞
152.5
145
*
ZX120
NOMESCO Finland
Intravenous
5.3
150.3
512
1140
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
16.9
145.5
238
153
L03AB13
ATC
peginterferon beta-1a; parenteral
+∞
140.8
134
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
10.2
136.4
283
306
G04BD04
ATC
oxybutynin; oral, transdermal
8.2
136.4
324
442
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
6.4
131.4
374
662
N06BA07
ATC
modafinil; oral
55.4
127.6
152
29
N03AX12
ATC
gabapentin; oral
3.6
121.8
655
2210
XKC03
NOMESCO Finland
Water cystometry
10.1
118.2
245
263
UKC02
NOMESCO Finland
Cystoscopy
4.1
112.4
494
1393
4AA23
NOMESCO Finland
NA
+∞
112.2
107
*
N03AE01
ATC
clonazepam; systemic
5.3
108.5
357
747
H53.2
ICD-10 Finland
Diplopia
9.8
102.2
215
236
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
29.0
100.9
138
50
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
4.7
100.0
373
891
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
18.5
97.4
153
87
G04BD07
ATC
tolterodine; oral
7.3
97.3
246
364
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
10.2
96.5
198
207
H48.1*G35
ICD-10 Finland
Retrobulbar neuritis in multiple sclerosis
+∞
96.4
92
*
R1250
NOMESCO Finland
Evaluation of functional capability
10.0
93.8
195
209
TKC22
NOMESCO Finland
Catheterisation instruction
14.1
88.1
154
115
G04BD08
ATC
solifenacin; oral
5.4
85.5
275
555
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
20.6
82.0
124
63
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
9.7
80.2
169
185
L04AA40
ATC
cladribine; oral
+∞
79.6
76
*
R35
ICD-10 Finland
Polyuria
5.3
77.8
252
511
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
27.8
77.6
107
40
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.5
76.0
293
715
SPAT1229
SPAT
Assessment of need for aid
4.4
73.2
285
701
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
24.8
72.4
103
43
N29
ICPC
Neurological sympt/complt other
10.9
71.0
140
135
H02AB04
ATC
methylprednisolone; systemic
2.8
70.4
528
2156
R33
ICD-10 Finland
Retention of urine
5.3
69.4
223
447
N03AX16
ATC
pregabalin; oral
2.3
66.0
730
3677
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.4
64.6
350
1141
J01EA01
ATC
trimethoprim; systemic
2.1
59.5
821
4545
N28
ICPC
Limited function/disability (N)
13.9
58.9
103
77
G36.0
ICD-10 Finland
Neuromyelitis optica [Devic]
+∞
58.5
56
*
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
38.0
58.1
74
20
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.6
58.0
491
2131
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.7
57.9
209
474
L28
ICPC
Limited function/disability (L)
2.8
56.7
403
1576
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.6
56.2
279
845
XKD03
NOMESCO Finland
Urethral pressure profilometry
7.8
55.4
132
177
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.1
54.5
787
4409
TKC20
NOMESCO Finland
Catheterisation of bladder
4.1
53.9
223
577
XCD10
NOMESCO Finland
Electrophysiological examination of eye
7.0
52.2
133
197
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
5.5
50.9
158
303
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
7.5
50.7
124
173
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
33.8
50.6
66
20
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.3
50.3
276
901
N32.83
ICD-10 Finland
Nozzle synergy in the bladder neck
47.9
50.3
61
13
36703
ICD-8 Finland
Inflammation of optic nerve and retina, Neuritis optica, retrobulbaris
135.0
50.0
53
*
G04BD11
ATC
fesoterodine; oral
6.3
49.7
138
230
G37.3
ICD-10 Finland
Acute transverse myelitis in demyelinating disease of central nervous system
+∞
49.1
47
*
R4150
NOMESCO Finland
Neuropsychological rehabilitation
12.9
49.0
88
70
N99
ICPC
Neurological disease other
12.2
48.3
89
75
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
5.9
48.3
140
247
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
12.4
48.1
88
73
L01BB04
ATC
cladribine; systemic
+∞
48.0
46
*
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.3
47.1
261
857
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.5
46.5
415
1836
R4110
NOMESCO Finland
Physiotherapy
2.0
46.3
714
4063
H53.1
ICD-10 Finland
Subjective visual disturbances
3.4
44.9
237
750
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.1
44.5
184
475
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.2
44.1
254
855
N03AF01
ATC
carbamazepine; oral, rectal
3.8
44.0
198
551
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
11.5
43.9
83
74
SPAT1231
SPAT
Assessment of adjustments needed in living environment
9.7
43.4
90
96
N05CF01
ATC
zopiclone; oral
1.9
43.3
836
5153
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
12.3
43.1
79
66
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
14.9
41.7
70
48
C10AC01
ATC
colestyramine; oral
5.3
41.6
132
260
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
19.5
41.4
63
33
4AA36
NOMESCO Finland
NA
+∞
40.7
39
*
3773B
ICD-9 Finland
Disorders of optic nerve and visual pathways, Optic neuritis[NEURITIS RETROBULBARIS]
403.2
40.2
40
*
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
13.2
40.1
71
55
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
5.9
39.8
115
202
H47.2
ICD-10 Finland
Optic atrophy
28.4
39.1
53
19
R4120
NOMESCO Finland
Occupational therapy
3.1
39.0
224
753
J01CA08
ATC
pivmecillinam; oral
1.7
36.7
1237
8974
L04AX01
ATC
azathioprine; systemic
3.3
36.3
191
602
RF120
NOMESCO Finland
NA
8.4
35.7
80
98
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
351.6
35.0
35
*
CS494
NOMESCO Finland
Other visual field testing
6.4
34.9
94
151
N30.0
ICD-10 Finland
Acute cystitis
2.2
34.6
405
2023
R42
ICD-10 Finland
Dizziness and giddiness
2.0
33.5
522
2931
3419X
ICD-9 Finland
Other demyelinating diseases of central nervous system, Demyelinating disease of central nervous system, unspecified
+∞
33.4
32
*
N04BD01
ATC
selegiline; oral
10.7
33.4
65
62
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
14.6
33.2
56
39
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
15.1
33.1
55
37
G50.0
ICD-10 Finland
Trigeminal neuralgia
6.4
33.1
89
143
A28
ICPC
Limited function/disability NOS
2.5
32.9
271
1137
A06AD11
ATC
lactulose; oral
2.4
32.4
311
1413
N06AX16
ATC
venlafaxine; oral
2.0
32.2
481
2654
N31.0
ICD-10 Finland
Uninhibited neuropathic bladder, not elsewhere classified
19.5
31.8
48
25
SPAT1216
SPAT
Assessment of functional ability
2.2
31.6
341
1639
G04CA02
ATC
tamsulosin; oral
2.4
31.3
293
1312
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
21.8
30.9
45
21
H02AB07
ATC
prednisone; oral
2.1
29.4
376
1943
M03BX02
ATC
tizanidine; oral
1.6
29.4
1750
14389
U07
ICPC
Urine symptom/complaint other
3.2
29.0
162
533
H51.2
ICD-10 Finland
Internuclear ophthalmoplegia
81.0
28.8
32
*
Z43.5
ICD-10 Finland
Attention to cystostomy
29.6
28.5
38
13
L89
ICD-10 Finland
Decubitus ulcer and pressure area
8.5
28.2
62
74
N06AA09
ATC
amitriptyline; systemic
2.3
26.7
273
1275
F02.89
ICD-10 Finland
Dementia in another specified disease that is classified elsewhere without information of additional symptoms
141.4
26.7
28
*
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.8
26.5
184
696
N04BC05
ATC
pramipexole; oral
2.7
26.4
188
723
N03AF02
ATC
oxcarbazepine; oral
3.6
26.4
125
363
SPAT1167
SPAT
Insertion of urinary catheter
5.7
26.3
77
139
34109
ICD-8 Finland
Other demyelinating diseases of central nervous system, Unspecified
+∞
26.1
25
*
U04
ICPC
Incontinence urine
3.5
26.0
126
373
R39.1
ICD-10 Finland
Other difficulties with micturition
4.7
24.7
85
184
U13
ICPC
Bladder symptom/complaint other
3.9
24.2
102
269
AA1AD
NOMESCO Finland
CT of head and brain
1.8
24.2
471
2829
A02BC02
ATC
pantoprazole; systemic
1.5
24.1
1591
13079
G81.9
ICD-10 Finland
Hemiplegia, unspecified
6.7
24.1
62
95
G37.8
ICD-10 Finland
Other specified demyelinating diseases of central nervous system
+∞
24.0
23
*
H48.1
ICD-10 Finland
Retrobulbar neuritis in diseases classified elsewhere
+∞
24.0
23
*
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
9.2
24.0
50
55
J01XX05
ATC
methenamine; oral
9.1
23.7
50
56
H47.0
ICD-10 Finland
Disorders of optic nerve, not elsewhere classified
17.4
23.1
36
21
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
23.0
480
2942
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
22.7
251
1213
RF420
NOMESCO Finland
NA
5.4
22.2
67
126
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.1
22.1
265
1327
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
22.0
522
3321
U05
ICPC
Urination problems other
3.4
22.0
111
340
Z50.1
ICD-10 Finland
Other physical therapy
2.7
21.8
153
584
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.0
21.6
282
1461
RF410
NOMESCO Finland
NA
5.8
21.4
61
107
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
21.4
270
1379
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
21.4
546
3547
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
21.1
334
1864
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.3
20.9
78
185
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
20.8
885
6526
R03CA02
ATC
ephedrine; oral
19.6
20.8
31
16
H53.4
ICD-10 Finland
Visual field defects
4.5
20.7
74
168
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.6
20.5
157
631
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.9
20.5
130
467
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
20.4
660
4559
G04BD01
ATC
emepronium; systemic
9.4
20.1
41
44
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
7.3
20.0
48
67
G70.0
ICD-10 Finland
Myasthenia gravis
17.4
20.0
31
18
H53.9
ICD-10 Finland
Visual disturbance, unspecified
3.4
19.7
99
303
H57.1
ICD-10 Finland
Ocular pain
3.0
19.6
115
394
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
5.3
19.5
60
116
J01XE01
ATC
nitrofurantoin; oral
4.3
19.3
72
171
R32
ICD-10 Finland
Unspecified urinary incontinence
3.9
19.0
79
207
N18
ICPC
Paralysis/weakness
5.4
18.9
57
108
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.1
18.8
236
1201
G82.2
ICD-10 Finland
Paraplegia, unspecified
11.5
18.5
34
30
U28
ICPC
Limited function/disability (U)
8.8
18.4
39
45
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
18.4
595
4096
G04CA01
ATC
alfuzosin; oral
2.4
18.2
161
700
WW400
NOMESCO Finland
Plasmaferesis
25.2
18.2
25
10
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.5
18.1
929
7084
N07AA02
ATC
pyridostigmine; systemic
11.5
18.0
33
29
SPAT1325
SPAT
Vaccination
1.5
17.6
698
5031
J01MA02
ATC
ciprofloxacin; systemic
1.5
17.6
852
6414
G51.0
ICD-10 Finland
Bell palsy
3.5
17.4
81
234
G04BE03
ATC
sildenafil; oral
6.7
17.4
44
67
H04.10
ICD-10 Finland
Dry eye syndrome
1.9
17.3
255
1385
359
Kela drug reimbursment
Mirabegroni
11.1
17.2
32
29
N06AB04
ATC
citalopram; systemic
1.6
17.2
570
3937
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.3
17.1
159
709
N06AX21
ATC
duloxetine; oral
1.8
16.9
316
1858
RS221
NOMESCO Finland
NA
4.4
16.6
60
139
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.3
16.5
83
256
N87
ICPC
Parkinsonism
7.5
16.4
38
51
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.0
16.2
96
332
G04BD10
ATC
darifenacin; oral
8.4
16.2
35
42
XCK10
NOMESCO Finland
Photography of fundus of eye
2.0
16.0
203
1038
R15
ICD-10 Finland
Faecal incontinence
3.6
15.8
71
200
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
15.8
249
1383
6BA02
NOMESCO Finland
NA
12.3
15.8
28
23
G04BDXX
ATC
NA
12.3
15.8
28
23
N30.9
ICD-10 Finland
Cystitis, unspecified
2.3
15.8
150
677
N07AA03
ATC
distigmine; systemic
15.7
15.7
25
16
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
10.4
15.7
30
29
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
4.6
15.6
54
120
SPAT1262
SPAT
Handing over of treatment supplies
1.7
15.4
363
2285
Z93.5
ICD-10 Finland
Cystostomy status
38.3
15.4
19
5
R20.0
ICD-10 Finland
Anaesthesia of skin
6.1
15.3
41
68
119
Kela drug reimbursment
Trigeminal neuralgia or glossofaryngeusneuralgia
10.9
15.0
28
26
R20.1
ICD-10 Finland
Hypoaesthesia of skin
7.4
14.9
35
48
NA1CM
NOMESCO Finland
Cervical spine extensive MRI examination with 3 Tesla magnet
15.1
14.9
24
16
R51.80
ICD-10 Finland
Headache
1.6
14.8
407
2675
K59.09
ICD-10 Finland
Constipation, unspecified
2.4
14.8
126
537
K59.0
ICD-10 Finland
Constipation
2.5
14.7
117
482
G04BE01
ATC
alprostadil; parenteral, urethral
6.9
14.7
36
53
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
14.6
283
1683
RF432
NOMESCO Finland
NA
36.2
14.4
18
5
G04BD
ATC
Drugs for urinary frequency and incontinence
17.0
14.3
22
13
U08
ICPC
Urinary retention
5.9
14.2
39
67
U29
ICPC
Urinary symptom/complaint other
3.2
13.9
73
233
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
4.2
13.7
52
127
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
4.0
13.7
54
137
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
3.7
13.5
58
159
36702
ICD-8 Finland
Inflammation of optic nerve and retina, Neuritis optica. Papillitis
140.6
13.5
14
*
108
Kela drug reimbursment
Myasthenia gravis
13.8
13.2
22
16
RS340
NOMESCO Finland
NA
9.1
13.2
27
30
N02BE01
ATC
paracetamol; systemic, rectal
1.4
13.2
2182
20030
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
5.5
13.1
38
70
H30.2
ICD-10 Finland
Posterior cyclitis
12.2
13.1
23
19
RS121
NOMESCO Finland
NA
7.1
13.0
31
44
ABD40
NOMESCO Finland
Implantation of spinal injection device
28.5
12.9
17
6
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
12.9
210
1180
NA7CM
NOMESCO Finland
Spine and spinal cord extensive MRI examination with 3 Tesla magnet
50.2
12.8
15
*
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
3.9
12.8
52
136
J01MA06
ATC
norfloxacin; oral
1.6
12.5
322
2072
G37.0
ICD-10 Finland
Diffuse sclerosis
+∞
12.5
12
*
S97
ICPC
Chronic ulcer skin
2.5
12.5
97
397
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
3.6
12.4
56
160
G20
ICD-10 Finland
Parkinson disease
3.7
12.4
53
145
R5110
SPAT
NA
3.3
12.4
60
182
RS222
NOMESCO Finland
NA
4.4
12.3
43
98
R47.1
ICD-10 Finland
Dysarthria and anarthria
7.0
12.1
29
42
R13
ICD-10 Finland
Dysphagia
2.1
12.0
131
632
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.1
11.7
64
212
U02
ICPC
Urinary frequency/urgency
1.6
11.7
292
1869
RF122
NOMESCO Finland
NA
12.6
11.6
20
16
3773A
ICD-9 Finland
Disorders of optic nerve and visual pathways, Optic neuritis[PAPILLITIS OPTICA]
65.2
11.6
13
*
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.7
11.6
228
1360
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
3.2
11.5
60
193
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.7
11.4
271
1707
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.2
11.4
57
178
N07AB01
ATC
carbachol; systemic
15.1
11.3
18
12
N03AX09
ATC
lamotrigine; oral
1.9
11.2
160
859
G61.9
ICD-10 Finland
Inflammatory polyneuropathy, unspecified
25.1
11.1
15
6
R31
ICD-10 Finland
Unspecified haematuria
2.0
11.0
143
740
AAH30
NOMESCO Finland
Thermal destruction of cranial nerve
43.5
10.9
13
*
U71
ICPC
Cystitis/urinary infection other
2.0
10.8
145
761
N06AX11
ATC
mirtazapine; oral
1.4
10.8
758
5999
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
3.4
10.7
51
154
SPAT1260
SPAT
Consultation of another employee
1.5
10.6
371
2574
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.2
10.5
102
468
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.5
10.5
84
348
G61.0
ICD-10 Finland
Guillain-Barré syndrome
9.2
10.5
21
23
1DB07
NOMESCO Finland
NA
110.4
10.4
11
*
G36.8
ICD-10 Finland
Other specified acute disseminated demyelination
+∞
10.4
10
*
34108
ICD-8 Finland
Other demyelinating diseases of central nervous system, Alii definiti
+∞
10.4
10
*
SPAT1293
SPAT
Other function in accordance with rehabilitation guidance nomenclature
5.9
10.4
28
48
R5599
NOMESCO Finland
Other rehabilitation service
2.8
10.4
66
242
J01MA12
ATC
levofloxacin; systemic
1.5
10.3
354
2441
XA412
NOMESCO Finland
VEP
32.6
10.3
13
*
G61.8
ICD-10 Finland
Other inflammatory polyneuropathies
23.4
10.2
14
6
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
10.2
658
5127
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
4.4
10.1
35
80
H52.1
ICD-10 Finland
Myopia
2.2
10.1
104
492
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.1
10.0
119
593
ZXA10
NOMESCO Finland
Bilateral
1.5
9.9
352
2447
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
4.0
9.9
38
96
N02AX02
ATC
tramadol; systemic, rectal
1.3
9.9
865
7066
SPAT1263
SPAT
Sampling
1.3
9.8
1005
8393
N06
ICPC
Sensation disturbance other
3.8
9.8
40
107
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
2.0
9.6
116
584
J01DB01
ATC
cefalexin; oral
1.3
9.6
2114
19591
J01MA01
ATC
ofloxacin; systemic
1.8
9.6
165
944
M05BA04
ATC
alendronic acid; oral
2.0
9.6
123
637
RF210
NOMESCO Finland
NA
2.4
9.6
79
336
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.5
9.6
311
2117
F05
ICPC
Visual disturbance other
2.7
9.6
61
225
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
9.5
182
1078
J05AB01
ATC
aciclovir; systemic
1.4
9.5
498
3736
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
12.4
9.3
16
13
Z73.6
ICD-10 Finland
Limitation of activities due to disability
5.3
9.3
27
51
R60.0
ICD-10 Finland
Localized oedema
1.7
9.3
197
1200
J05AB11
ATC
valaciclovir; oral
1.5
9.2
307
2105
R27.0
ICD-10 Finland
Ataxia, unspecified
7.3
9.2
21
29
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
4.4
9.2
32
74
G97.1
ICD-10 Finland
Other reaction to spinal and lumbar puncture
7.7
9.1
20
26
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.9
9.1
54
191
SPAT1234
SPAT
Support of social functional capacity
2.2
9.1
89
412
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
9.0
9.0
18
20
H50.52
ICD-10 Finland
Exophoria
3.8
8.8
35
92
XKW99
NOMESCO Finland
Other physiological examination of urinary or male genital system
5.9
8.7
23
39
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.0
8.7
110
567
N06AB10
ATC
escitalopram; oral
1.4
8.7
547
4234
H02AB06
ATC
prednisolone; systemic
1.3
8.5
1024
8692
SPAT1254
SPAT
Administration of medicine
1.5
8.4
268
1817
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
6.0
8.4
22
37
R53
ICD-10 Finland
Malaise and fatigue
1.4
8.4
443
3325
NA1BM
NOMESCO Finland
Cervical spine MRI examination with 3 Tesla magnet
7.9
8.4
18
23
SPAT1281
SPAT
Other administrative function
1.7
8.3
174
1059
H02AB02
ATC
dexamethasone; systemic
0.5
8.3
71
1346
XA402
NOMESCO Finland
ENMG
2.4
8.2
67
284
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
1.9
8.2
118
637
R30.1
ICD-10 Finland
Vesical tenesmus
3.2
8.1
41
131
G83.9
ICD-10 Finland
Paralytic syndrome, unspecified
17.2
8.1
12
7
KCW98
NOMESCO Finland
Other transluminal endoscopic operation on bladder
11.7
8.1
14
12
U01
ICPC
Dysuria/painful urination
1.7
8.0
168
1027
XKX00
NOMESCO Finland
Pelvic floor electromyography
7.2
8.0
18
25
A02BA02
ATC
ranitidine; systemic
1.4
7.9
361
2633
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.8
7.9
125
698
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.5
7.9
322
2301
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.3
7.9
38
118
T83.0
ICD-10 Finland
Mechanical complication of urinary (indwelling) catheter
45.1
7.7
9
*
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.5
7.7
239
1609
N05BA01
ATC
diazepam; systemic, rectal
1.5
7.7
275
1912
RF310
NOMESCO Finland
NA
6.4
7.7
19
30
M05BX04
ATC
denosumab; parenteral
2.2
7.7
72
328
H20.1
ICD-10 Finland
Chronic iridocyclitis
3.6
7.6
32
89
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
3.8
7.6
30
79
CA1DG
NOMESCO Finland
Eye and orbita very extensive MRI examination with high intensity magnet
18.4
7.6
11
6
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
7.6
126
2006
RF312
NOMESCO Finland
NA
10.0
7.5
14
14
G83.1
ICD-10 Finland
Monoplegia of lower limb
10.0
7.5
14
14
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
4.6
7.5
24
52
TKC10
SPAT
NA
80.3
7.4
8
*
SPAT1301
SPAT
No procedures
1.3
7.4
653
5304
D12
ICPC
Constipation
2.4
7.3
58
244
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.8
7.3
122
697
H01AA02
ATC
tetracosactide; parenteral
+∞
7.3
7
*
G37.1
ICD-10 Finland
Central demyelination of corpus callosum
+∞
7.3
7
*
4AA34
NOMESCO Finland
NA
+∞
7.3
7
*
3418X
ICD-9 Finland
Other demyelinating diseases of central nervous system
+∞
7.3
7
*
Z74.0
ICD-10 Finland
Need for assistance due to reduced mobility
+∞
7.3
7
*
SPAT1172
SPAT
Guidance concerning hydration
3.2
7.3
35
109
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.6
7.3
167
1045
A04
ICPC
Weakness/tiredness general
1.5
7.3
264
1845
A04AA55
ATC
palonosetron, combinations; systemic
0.2
7.2
10
405
D17
ICPC
Incontinence of bowel
5.4
7.2
20
37
SPAT1312
SPAT
General health counselling
1.3
7.2
726
6000
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.3
7.1
65
291
W19
ICD-10 Finland
Unspecified fall
1.6
7.1
175
1115
R2110
NOMESCO Finland
Giving the first information
1.6
7.1
181
1164
K07
ICPC
Swollen ankles/oedema
2.3
7.1
63
282
RS130
NOMESCO Finland
NA
5.6
7.1
19
34
L17
ICPC
Foot/toe symptom/complaint
1.3
7.0
493
3870
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
6.3
6.9
17
27
N86
ICD-10 Finland
Erosion and ectropion of cervix uteri
5.5
6.9
19
35
R30.0
ICD-10 Finland
Dysuria
2.0
6.9
81
409
R26.0
ICD-10 Finland
Ataxic gait
13.8
6.9
11
8
G11.9
ICD-10 Finland
Hereditary ataxia, unspecified
13.8
6.9
11
8
SPAT1125
SPAT
Stoma care and guidance
4.4
6.8
23
53
SPAT1171
SPAT
Bladder puncture
40.1
6.8
8
*
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
3.7
6.8
27
73
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
3.7
6.8
27
73
G04AC01
ATC
NA
2.1
6.8
70
334
34400
ICD-8 Finland
Other cerebral paralysis, Hemiplegia NUD
16.7
6.7
10
6
RF311
NOMESCO Finland
NA
16.7
6.7
10
6
KH1AT
NOMESCO Finland
Urinary tract cathetrisation with ultrasound guidance
22.6
6.7
9
*
N03AX14
ATC
levetiracetam; systemic
2.2
6.7
60
271
183
Kela drug reimbursment
Lamotrigin and topiramate
3.1
6.6
33
106
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.7
6.6
315
4134
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.2
6.6
937
8054
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.5
6.6
260
1843
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
2.1
6.6
72
353
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
2.5
6.6
50
206
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
6.6
802
6771
A29
ICPC
General symptom/complaint other
1.5
6.6
204
1379
H81.4
ICD-10 Finland
Vertigo of central origin
4.8
6.5
20
42
N04BC04
ATC
ropinirole; oral
4.8
6.5
20
42
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
6.5
249
1760
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
3.7
6.5
26
71
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
2.8
6.5
38
136
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.7
6.4
133
812
R83.4
ICD-10 Finland
Abnormal findings in cerebrospinal fluid, Abnormal immunological findings
70.0
6.4
7
*
3499X
ICD-9 Finland
Other and unspecified disorders of the nervous system, Unspecified disorders of nervous system
70.0
6.4
7
*
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
4.3
6.4
22
52
KCE02
NOMESCO Finland
Transluminal endoscopic extraction of calculus from bladder
7.4
6.4
14
19
G04BE08
ATC
tadalafil; oral
14.3
6.4
10
7
N27
ICPC
Fear of neurological disease other
3.5
6.4
27
77
M48.0
ICD-10 Finland
Spinal stenosis
1.6
6.3
165
1071
D21
ICPC
Swallowing problem
3.5
6.3
27
78
R5130
SPAT
NA
18.0
6.3
9
5
Z46.6
ICD-10 Finland
Fitting and adjustment of urinary device
+∞
6.2
6
*
A06AC51
ATC
ispaghula, combinations; systemic
1.8
6.2
96
536
A46
ICD-10 Finland
Erysipelas
1.5
6.2
206
1411
K59.01
ICD-10 Finland
Constipation outlet obstruction type
3.1
6.2
31
101
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.4
6.2
47
194
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
2.6
6.1
41
159
A02BA04
ATC
nizatidine; systemic
1.7
6.1
127
777
NA1DG
NOMESCO Finland
Cervical spine very extensive MRI examination with high intensity magnet
7.7
6.1
13
17
H52.2
ICD-10 Finland
Astigmatism
2.8
6.1
36
130
G04BX05
ATC
NA
12.5
6.1
10
8
G96.9
ICD-10 Finland
Disorder of central nervous system, unspecified
12.5
6.1
10
8
U72
ICPC
Urethritis
2.2
6.0
55
249
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022096) Basophils/100 leukocytes in Blood
2216
11208
4.52
323.31
13.1
5.9
%
0.8
0.7
11.34
2179
10510
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
248
131
20.51
319.92
1.1
1.1
miu/ml
1735.0
1531.1
1.05
248
131
(3028026) IgM [Mass/volume] in Serum or Plasma
678
1427
5.81
316.28
3.6
1.7
g/l
1.0
1.4
7.67
666
1323
(3013115) Eosinophils [#/volume] in Blood
2391
12905
4.86
315.74
13.6
6.0
e9/l
0.2
0.2
0.06
2243
11538
(3019069) Monocytes/100 leukocytes in Blood
2247
11684
4.45
310.11
13.2
6.0
%
9.1
8.2
52.37
2211
11023
(3019198) Lymphocytes [#/volume] in Blood
2375
12861
4.74
309.35
13.5
5.7
e9/l
1.7
2.0
10.96
2236
11527
(3006504) Eosinophils/100 leukocytes in Blood
2236
11599
4.42
309.32
13.1
5.8
%
3.0
2.8
4.91
2199
10858
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
340
134
28.41
307.65
4.2
2.1
e9/l
0.3
0.2
1.72
297
112
(3011412) CD3 cells [#/volume] in Blood
409
196
23.92
307.65
3.8
2.0
e9/l
1.3
1.3
0.09
193
125
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
343
137
28.06
307.65
4.2
2.0
e6/l
473.1
627.0
1.29
296
111
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
528
532
11.78
307.65
1.1
1.4
e6/l
36.4
22.0
0.25
422
406
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
682
399
21.69
307.65
1.2
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
635
594
13.22
307.65
1.1
1.3
mg/l
425.6
477.0
1.68
609
564
(21494815) CD4 cells/100 lymphocytes in Specimen
314
180
19.32
307.65
2.7
2.1
%
48.8
40.1
1.12
104
15
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
208
45
49.51
307.65
1.0
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
462
8
676.27
307.65
2.9
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
483
237
24.00
307.65
1.0
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
375
151
28.15
307.65
1.0
1.1
u/l
1.0
1.0
1.76
131
71
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
569
193
35.96
307.65
1.1
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
508
539
11.10
307.65
1.1
1.3
mmol/l
3.6
3.7
1.44
470
506
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
564
197
34.85
307.65
1.1
1.1
mg/l
215.9
226.0
0.48
487
170
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
345
155
24.95
307.65
2.7
1.8
%
15.4
12.8
1.81
168
81
(3005719) IgG [Mass/volume] in Serum or Plasma
1024
1829
7.90
307.65
3.6
2.5
g/l
9.9
10.6
6.87
940
1691
(3006315) Basophils [#/volume] in Blood
2370
12447
4.97
307.65
13.5
5.7
e9/l
0.0
0.0
0.60
2219
10918
(3014148) Varicella zoster virus Ab [Titer] in Serum
674
383
22.27
307.65
1.2
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
596
810
8.89
307.65
1.9
1.6
iu/ml
62.9
0.2
0.59
39
159
(3044290) Cell count panel - Cerebral spinal fluid
561
486
13.90
307.65
1.1
1.5
—
—
—
0
0
(4027681)
467
167
32.80
307.65
1.3
1.2
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
178
17
111.09
307.65
1.1
1.0
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
269
150
19.56
307.65
4.7
2.3
e6/l
972.8
712.1
2.51
176
48
(42870588) Differential panel, method unspecified - Blood
1897
7889
4.68
307.65
11.5
5.8
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
2369
12410
4.99
307.65
13.4
5.7
e9/l
0.5
0.5
0.29
2215
10902
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
574
207
33.88
307.65
1.1
1.2
mg/l
56.2
33.1
12.69
467
175
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
527
531
11.77
307.65
1.2
1.5
e6/l
551.3
1661.2
0.97
431
427
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
321
28
127.92
307.65
1.2
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
250
158
17.14
295.77
2.9
1.9
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
190
62
32.60
293.20
3.0
1.7
e6/l
49.5
175.1
3.61
84
35
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
180
49
38.96
292.54
4.8
2.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
289
244
12.97
290.27
1.1
1.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
2259
12134
4.26
288.89
13.1
5.8
%
26.3
29.3
37.21
2220
11401
(3018010) Neutrophils/100 leukocytes in Blood
2232
11983
4.16
283.31
12.7
5.6
%
59.0
56.5
21.64
2195
11291
(21494814) CD8 cells/100 lymphocytes in Specimen
181
72
26.65
261.20
2.2
1.9
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
2424
14266
4.33
257.34
14.2
8.7
e9/l
3.7
4.0
14.50
2273
12573
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
661
1734
4.58
233.11
1.3
1.3
au/ml
19.1
42.6
—
9
78
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
692
1883
4.45
232.73
2.5
2.3
au/ml
40.1
22.0
1.62
21
150
(3023410) Appearance of Cerebral spinal fluid
257
256
10.87
230.67
1.2
1.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1419
6523
3.19
211.45
4.9
2.9
e6/l
21.1
96.9
2.51
1218
4889
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1893
10277
3.20
210.23
2.5
2.2
nmol/l
92.0
74.6
82.56
1788
9509
(3000850) Epithelial cells [#/volume] in Urine
1115
4498
3.32
206.57
3.6
2.4
e6/l
4.7
7.3
10.38
1032
3926
(3030467) Casts [#/volume] in Urine by Automated count
1319
5941
3.14
201.51
4.6
2.8
e6/l
0.1
0.4
8.47
1108
4376
(36304419) Bacteria [Presence] in Urine
1309
5953
3.09
195.33
4.5
2.7
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
192
172
11.84
184.67
1.1
1.4
mmol/l
1.7
1.9
3.95
177
160
(3018095) Leukocytes [#/volume] in Urine
1547
8002
2.88
178.14
6.0
3.3
e6/l
82.4
77.4
0.11
1262
5383
(3026782) Osmolality of Urine
1000
4154
3.09
171.16
3.7
2.5
mosm/kgh2o
554.6
540.3
1.24
914
3539
(3031040) Bacteria [#/volume] in Urine by Automated count
2401
16058
3.28
165.44
8.7
3.8
e6/l
2939.2
1687.3
0.30
34
187
(3026008) Bacteria identified in Urine by Culture
1298
6431
2.76
157.54
4.7
2.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1840
11018
2.67
149.94
13.9
8.3
e9/l
0.0
0.0
0.23
1603
9030
(3021879) Hepatitis B virus core Ab [Presence] in Serum
669
2457
3.20
138.31
1.3
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
2413
17016
2.96
134.54
8.1
3.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
811
3552
2.74
119.93
4.3
2.4
e6/l
0.9
1.2
1.08
498
1912
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
120
115
10.82
109.88
1.1
1.4
%
94.2
61.3
2.68
19
13
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
129
138
9.71
109.20
3.9
2.7
%
48.5
43.7
1.04
51
38
(3035350) Ketones [Presence] in Urine by Test strip
1851
12188
2.31
107.09
6.2
3.2
estimate
0.0
0.0
1.08
437
2257
(3009261) Glucose [Presence] in Urine by Test strip
1863
12337
2.30
105.78
6.3
3.2
estimate
0.0
0.0
1.32
449
2255
(3021601) Nitrite [Presence] in Urine by Test strip
1852
12244
2.29
105.43
8.3
4.4
estimate
0.0
0.0
0.37
449
2333
(3015736) pH of Urine
1530
9384
2.26
104.15
5.2
3.0
—
5.9
—
0
7
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
731
3313
2.58
98.62
4.5
2.6
e6/l
5.3
3.6
1.87
417
1680
(3002179) Metamyelocytes/100 leukocytes in Blood
474
1758
3.01
93.71
5.7
4.1
%
0.2
0.6
3.77
85
364
(3017181) Myelocytes/100 leukocytes in Blood
502
1928
2.92
93.14
5.8
4.3
%
0.5
0.9
2.93
109
492
(3025159) Blasts/100 leukocytes in Blood
465
1741
2.97
90.19
6.0
4.4
%
0.0
0.5
0.95
91
381
(3021440) Promyelocytes/100 leukocytes in Blood
478
1841
2.89
87.92
6.0
4.3
%
0.0
0.1
1.38
101
452
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
84
68
12.67
85.71
1.1
1.2
%
4.0
24.3
—
17
6
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
337
1074
3.40
85.66
1.4
2.1
u/l
36.1
39.8
3.01
316
982
(3024561) Albumin [Mass/volume] in Serum or Plasma
1439
9194
2.06
81.70
3.7
4.6
g/l
37.4
36.5
8.42
1341
8597
(3017143) Hepatitis C virus Ab [Presence] in Serum
746
3772
2.29
76.62
1.5
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
1057
6169
2.09
75.24
8.8
6.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
187
467
4.20
67.47
4.3
3.9
%
60.1
56.8
3.01
187
467
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1675
11781
1.93
67.45
5.1
5.8
umol/l
9.7
10.5
3.54
1607
11152
(40760892) CBC W Ordered Manual Differential panel - Blood
1033
6187
2.01
66.83
10.0
4.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
71
66
10.99
66.22
2.0
1.9
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
930
5460
2.01
62.96
5.3
3.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
953
5760
1.95
58.53
1.6
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
217
674
3.39
56.91
1.3
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
78
105
7.60
54.77
1.1
1.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
322
1309
2.63
52.08
2.7
1.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
908
5602
1.88
51.11
2.5
1.4
g/l
2.0
2.2
6.08
681
3609
(3018677) aPTT in Platelet poor plasma by Coagulation assay
582
3106
2.08
49.77
1.9
2.1
s
29.3
29.4
0.38
562
3006
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
66
85
7.91
48.12
1.2
1.0
ng/l
37.5
425.6
0.81
24
12
(3020630) Protein [Mass/volume] in Serum or Plasma
317
1369
2.47
44.96
1.5
2.5
g/l
68.3
67.3
1.78
301
1266
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
259
1028
2.66
43.74
1.4
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
391
1885
2.23
42.97
2.6
2.2
u/l
2608.4
5381.6
1.03
98
770
(3013826) Glucose [Moles/volume] in Serum or Plasma
1703
13205
1.65
39.28
4.1
4.3
mmol/l
6.2
6.5
8.75
1607
12143
(3041096) Erythrocytes [Presence] in Urine by Automated
1032
7058
1.70
38.65
6.1
2.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1318
9632
1.65
38.05
7.1
3.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2187
18181
1.71
37.68
6.4
7.1
u/l
73.4
74.5
0.71
2062
17209
(46235355) HIV 1 and 2 tests - Meaningful Use set
1021
7017
1.68
37.24
1.8
2.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
951
6428
1.69
36.85
7.7
3.5
estimate
0.0
0.0
1.49
446
2291
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
925
6226
1.70
36.31
2.1
2.0
u/l
136.8
205.7
2.10
880
5915
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
64
114
5.71
34.42
1.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
85
202
4.30
32.68
1.2
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
391
2139
1.95
30.08
7.4
3.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
61
119
5.21
29.75
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
44
65
6.85
28.44
1.0
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2933
27347
2.64
28.36
15.9
9.0
u/l
26.8
26.2
1.04
2874
26581
(3023511) Choriogonadotropin [Units/volume] in Urine
221
1000
2.30
27.92
1.7
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2806
25737
2.05
27.59
14.7
11.3
mg/l
20.9
20.3
0.33
2178
19990
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2167
18559
1.57
27.31
4.4
2.9
u/l
42.5
40.1
0.62
2085
17681
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
34
40
8.58
26.64
1.0
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2290
25296
0.63
25.73
3.6
3.8
mmol/l
1.5
1.5
0.05
2099
23922
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
42
66
6.44
25.63
1.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
42
66
6.44
25.63
1.0
1.1
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
2900
27125
2.26
23.97
16.3
12.3
umol/l
67.1
71.2
18.88
2900
27116
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1126
8559
1.50
23.96
3.8
3.1
u/l
29.7
31.0
0.52
1090
8169
(3019550) Sodium [Moles/volume] in Serum or Plasma
2751
25293
1.85
23.48
13.9
11.7
mmol/l
139.7
139.6
0.87
2696
24636
(3052851) Hemolysis interference index of Serum or Plasma
153
635
2.48
23.43
2.2
3.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2196
24371
0.65
23.31
3.3
3.4
mmol/l
1.3
1.3
0.38
2022
22977
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2346
25669
0.63
23.23
3.9
4.1
mmol/l
2.9
2.9
0.01
2145
24199
(3023103) Potassium [Moles/volume] in Serum or Plasma
2757
25389
1.84
23.07
13.9
11.8
mmol/l
3.9
3.9
3.15
2696
24680
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2318
25403
0.64
22.64
3.6
3.8
mmol/l
4.8
4.8
0.22
2142
24110
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
74
208
3.62
22.63
1.2
1.7
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
39
65
6.06
22.48
1.0
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
38
62
6.19
22.37
1.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
44
83
5.36
22.30
1.0
1.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1034
7822
1.49
22.08
5.7
6.6
inr
1.1
1.1
2.92
323
2456
(3002385) Erythrocyte distribution width [Ratio]
2474
22213
1.59
21.90
21.9
13.6
%
13.4
13.5
5.48
2445
21759
(3023368) Bacteria identified in Blood by Culture
724
5107
1.55
21.46
4.4
4.0
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
26
29
9.03
21.20
1.1
1.1
%
91.4
41.0
3.35
17
12
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1310
10493
1.43
20.22
5.5
6.1
mmol/l
1.2
1.2
3.99
1077
8919
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
475
3077
1.64
20.07
1.9
1.8
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
794
5841
1.48
18.91
3.5
3.6
%
97.2
95.7
1.18
781
5676
(3008757) Leukocyte morphology finding [Identifier] in Blood
66
200
3.35
18.05
3.1
3.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1075
8464
1.42
17.55
1.8
1.8
pmol/l
95.5
97.9
0.86
548
4519
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2595
23879
1.56
17.26
13.1
9.8
ml/min/173m2
94.5
88.9
38.71
2229
19654
(3004588) Protein electrophoresis panel - Serum or Plasma
208
1117
1.92
16.67
1.6
2.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
556
3920
1.51
15.96
1.4
1.4
titre
402.2
559.4
2.65
145
793
(1761868) Lipid panel - Serum or Plasma
840
10646
0.71
15.40
2.4
2.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1158
9418
1.37
14.91
4.9
5.4
mmol/l
1.2
1.2
2.14
1045
8603
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
22
31
7.14
14.82
1.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
22
32
6.92
14.41
1.0
1.0
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
87
356
2.49
13.83
1.3
1.8
—
1366.7
—
0
12
(3018418) pH of Serum or Plasma
804
6224
1.40
13.78
3.3
3.8
ph
7.4
7.4
0.01
147
1183
(40761535) Cells panel - Urine sediment
275
1706
1.67
13.55
6.5
3.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
240
3835
0.59
13.37
1.3
1.3
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
20
29
6.94
13.14
1.0
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
317
2061
1.60
12.94
1.7
1.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
2056
18472
1.34
12.68
3.4
3.8
mm/h
10.0
10.1
0.15
1920
17328
(3019150) Specific gravity of Urine by Refractometry
688
5258
1.40
12.55
6.9
3.5
kg/l
1.0
1.0
0.38
101
758
(3004809) Band form neutrophils/100 leukocytes in Blood
74
295
2.55
12.46
3.0
3.1
%
0.5
1.6
4.76
63
243
(3013512) EKG study
736
5737
1.37
11.81
3.4
3.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
315
2094
1.56
11.66
1.7
1.7
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
30
72
4.20
11.52
1.1
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
51
178
2.90
11.12
2.9
2.9
%
49.3
54.5
0.81
38
124
(3017732) Neutrophils [#/volume] in Blood
281
1841
1.58
11.08
2.2
2.6
e9/l
4.0
4.1
0.45
241
1534
(3019309) Folate [Moles/volume] in Red Blood Cells
465
3404
1.43
10.69
1.7
1.7
nmol/l
1054.5
1195.7
2.23
351
2642
(3000330) Specific gravity of Urine by Test strip
173
1010
1.76
10.64
6.3
2.9
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
16
23
6.99
10.57
1.0
1.2
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
16
23
6.99
10.57
1.0
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
592
4530
1.38
10.51
1.5
1.5
nmol/l
20.2
20.8
0.31
512
3991
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
174
1023
1.74
10.45
1.6
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2553
23957
1.39
10.30
5.4
4.8
mu/l
1.7
2.0
1.95
2383
22559
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
136
747
1.86
10.24
1.5
1.6
titre
80.6
254.5
—
8
29
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
54
205
2.66
10.09
1.1
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
126
2226
0.55
10.08
1.6
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
183
1104
1.70
10.03
1.8
1.8
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
28
72
3.92
9.85
3.3
2.6
umol/l
23.7
30.2
1.51
19
55
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
112
594
1.92
9.42
1.6
2.1
g/l
2.8
3.1
2.61
89
472
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
116
624
1.89
9.35
1.6
2.0
g/l
6.8
7.3
2.82
92
488
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
116
624
1.89
9.35
1.6
2.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
132
741
1.82
9.30
2.1
1.8
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
189
1175
1.65
9.25
1.2
1.3
u/ml
2.7
1.0
—
9
103
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
115
624
1.88
9.03
1.6
2.0
g/l
3.4
3.7
2.32
88
458
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
81
389
2.11
8.98
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
81
389
2.11
8.98
1.3
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
218
3231
0.65
8.55
1.5
1.6
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
106
571
1.89
8.53
1.7
2.1
g/l
9.1
10.4
3.75
93
498
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
928
7770
1.28
8.49
3.2
2.9
ng/l
36.1
42.6
0.23
533
4137
(3022621) pH of Urine by Test strip
231
1555
1.53
8.08
4.4
2.5
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
24
64
3.77
8.06
1.1
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
20
48
4.19
7.73
1.6
1.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
15
28
5.38
7.72
1.0
1.2
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
120
695
1.76
7.67
1.6
2.1
mg/l
9.2
10.9
2.00
115
653
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
12
18
6.69
7.60
1.0
1.1
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
59
270
2.21
7.45
1.4
1.4
g/l
0.3
0.4
1.42
39
189
(3028192) IgG subclass 2 [Mass/volume] in Serum
59
270
2.21
7.45
1.4
1.4
g/l
2.6
3.0
0.96
40
190
(3027135) IgG subclass 1 [Mass/volume] in Serum
59
271
2.20
7.38
1.4
1.4
g/l
6.0
6.6
0.77
40
192
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
20
50
4.02
7.34
1.0
1.1
—
—
—
0
0
(4062490)
59
274
2.18
7.19
1.5
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
47
203
2.34
6.82
1.7
3.4
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
11
17
6.49
6.77
1.0
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
133
824
1.64
6.68
2.2
1.9
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
88
486
1.83
6.64
1.7
2.1
g/l
0.0
0.0
0.65
83
455
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
196
1333
1.50
6.57
1.2
1.3
miu/ml
184.2
223.0
0.87
74
687
(3016650) Hepatitis A virus Ab [Presence] in Serum
87
482
1.83
6.50
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
293
3912
0.72
6.44
1.4
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
81
441
1.86
6.40
11.0
3.7
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
94
536
1.78
6.40
1.7
2.2
g/l
0.4
0.7
0.89
88
484
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
88
493
1.81
6.35
1.6
2.1
g/l
40.0
38.4
1.53
82
435
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
99
575
1.75
6.33
1.2
1.4
—
5.9
—
0
13
(3045424) Erythrocytes [Presence] in Urine
78
422
1.87
6.29
1.4
1.5
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
82
451
1.84
6.28
1.7
2.1
g/l
0.0
0.0
0.00
77
421
(3014576) Chloride [Moles/volume] in Serum or Plasma
311
2326
1.38
6.23
6.1
7.0
mmol/l
104.7
104.6
0.14
296
2274
(3015377) Calcium [Moles/volume] in Serum or Plasma
864
7391
1.24
6.20
2.6
3.2
mmol/l
2.3
2.3
0.14
748
6641
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
357
2733
1.35
6.16
2.2
2.7
umol/l
6.0
7.1
0.74
310
2342
(3007566) Smooth muscle Ab [Titer] in Serum
119
737
1.64
6.02
1.3
1.3
titre
112.4
126.7
0.11
17
72
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
29
106
2.75
5.95
1.1
1.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
267
1964
1.39
5.91
3.4
2.6
%
1.6
1.8
3.74
230
1753
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
557
4555
1.27
5.90
1.5
1.6
pmol/l
453.4
36259966.8
3.98
474
3930
(3000492) Spirometry study
194
2719
0.69
5.67
1.3
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
2815
27289
1.38
5.67
14.2
10.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
137
893
1.56
5.62
1.7
2.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
34
139
2.46
5.61
1.3
3.6
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
11
21
5.25
5.52
1.5
1.5
mg/l
1.6
0.8
—
6
14
(3014051) Protein [Presence] in Urine by Test strip
91
538
1.71
5.51
2.1
2.0
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
39
172
2.28
5.46
1.0
1.1
nmol/l
4.8
5.8
—
9
28
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
153
2222
0.67
5.42
1.3
1.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
25
89
2.82
5.40
1.0
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2108
22284
0.83
5.39
4.4
4.7
mmol/mol
37.6
38.3
3.39
1948
21053
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
127
828
1.56
5.23
1.1
1.2
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
0
+∞
5.21
1.0
0.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
22
75
2.95
5.14
1.1
1.3
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
37
164
2.27
5.14
1.2
1.1
u/ml
1.8
34.9
—
5
13
(3007461) Platelets [#/volume] in Blood
2970
29133
1.60
5.12
27.0
16.6
e9/l
263.1
261.7
0.55
2938
28561
(3010813) Leukocytes [#/volume] in Blood
2972
29164
1.60
5.02
27.0
16.7
e9/l
6.4
6.7
5.75
2934
28533
(3024731) MCV [Entitic volume]
2971
29153
1.60
5.01
26.8
16.6
fl
90.8
90.3
8.32
2953
28854
(3035941) MCH [Entitic mass]
2971
29155
1.60
4.98
26.8
16.5
pg
30.2
30.1
3.03
2953
28854
(3026361) Erythrocytes [#/volume] in Blood
2971
29159
1.59
4.93
26.9
16.6
e12/l
4.5
4.5
0.46
2934
28536
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
42
201
2.10
4.86
1.0
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
228
1692
1.38
4.82
4.0
3.4
mmol/l
1.2
1.2
0.33
192
1466
(3000963) Hemoglobin [Mass/volume] in Blood
2971
29168
1.58
4.81
27.1
16.7
g/l
136.0
135.8
0.36
2954
28858
(3003338) MCHC [Mass/volume]
2216
23244
0.83
4.79
23.2
14.1
g/l
332.5
332.7
0.25
2205
23083
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
32
138
2.33
4.75
1.6
2.8
u/ml
763.9
897.7
0.17
32
138
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
269
3476
0.75
4.72
1.8
1.9
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
74
436
1.71
4.60
1.5
1.7
g/l
0.5
0.7
1.07
52
336
(3023520) Reticulocytes [#/volume] in Blood
190
1382
1.40
4.55
2.5
2.7
e9/l
62.1
73.4
4.70
141
1027
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
832
7280
1.20
4.51
2.3
2.5
u/l
51.6
56.3
4.39
767
6776
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
271
2089
1.33
4.49
2.6
4.3
u/l
226.5
239.8
0.86
256
1984
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
81
1285
0.62
4.39
1.6
1.7
mg/l
5.1
4.0
0.34
49
893
(3009508) Creatinine [Moles/volume] in Urine
545
6417
0.82
4.37
3.7
3.2
mmol/l
8.0
7.8
0.32
468
5519
(1002224) Polysomnography panel
87
1355
0.63
4.35
1.1
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
19
66
2.89
4.33
1.2
1.1
%
89.6
96.9
0.38
19
66
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
19
66
2.89
4.33
1.2
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
63
1053
0.59
4.23
1.5
1.8
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
50
888
0.56
4.21
1.3
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
185
2476
0.73
4.13
1.4
1.5
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
125
860
1.47
4.07
1.7
1.8
g/l
1.2
1.2
0.01
120
806
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
15
47
3.20
4.05
1.0
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
455
3793
1.23
4.02
2.9
3.2
ng/l
340.6
494.1
0.43
255
2394
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
121
832
1.47
3.96
1.7
1.9
g/l
0.2
0.2
0.55
116
780
(3049717) Cytology report of Urine Cyto stain
86
549
1.58
3.96
2.2
2.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
465
5508
0.82
3.92
3.8
3.3
mg/l
924.1
323.6
1.00
301
3456
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
396
4766
0.81
3.89
1.2
1.3
u/ml
3.8
9.2
2.80
154
2024
(3027273) Bicarbonate [Moles/volume] in Venous blood
120
828
1.47
3.87
3.3
3.3
mmol/l
26.0
25.2
2.09
112
799
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
18
65
2.78
3.85
1.2
1.4
nmol/l
94.3
103.1
0.12
12
49
(3015183) Erythrocyte sedimentation rate
5
205
0.24
3.81
1.2
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
491
5768
0.82
3.80
4.5
4.0
mg/mmol
5.5
9.6
3.03
311
3673
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
14
44
3.19
3.77
1.1
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
25
109
2.30
3.68
1.1
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
60
359
1.68
3.60
1.1
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
264
2095
1.28
3.57
3.5
2.8
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
22
92
2.40
3.55
1.4
1.3
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
104
711
1.48
3.54
4.2
6.3
%
1.9
1.7
0.85
97
660
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
189
1435
1.34
3.52
1.8
1.6
—
—
—
0
0
(3019225) pH of Specimen
253
2001
1.29
3.51
3.7
3.7
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
8
13
6.17
3.50
3.5
5.8
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
121
1685
0.71
3.48
1.3
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
136
984
1.40
3.43
1.2
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
36
187
1.94
3.43
1.1
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
23
100
2.31
3.42
2.1
2.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
339
2791
1.24
3.37
1.9
1.6
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
36
189
1.92
3.33
1.1
1.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
22
95
2.33
3.33
1.4
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
117
830
1.43
3.31
4.3
3.2
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
102
710
1.45
3.20
4.3
6.3
%
0.9
0.9
0.67
96
660
(3003694) ABO and Rh group [Type] in Blood
705
7918
0.86
3.18
1.5
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
45
258
1.76
3.18
1.2
1.5
—
—
—
0
0
(4024509)
37
200
1.86
3.16
1.8
1.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
153
1146
1.35
3.15
4.0
3.2
kpa
5.2
5.1
0.43
144
1079
(3009343) pH of Capillary blood
151
1133
1.35
3.08
4.0
3.2
ph
7.4
7.4
0.32
17
141
(3008898) HLA-B27 [Presence]
93
1322
0.69
3.04
1.1
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
23
106
2.18
3.02
1.8
1.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
146
1094
1.35
3.01
4.0
3.1
mmol/l
1.9
1.6
0.57
126
808
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
57
356
1.61
2.96
1.2
1.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
92
639
1.45
2.95
1.9
2.3
ug/l
260.9
338.4
0.33
83
585
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
72
476
1.52
2.94
1.0
1.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
395
3354
1.20
2.91
2.6
3.4
mmol/l
0.8
0.8
0.94
362
3154
(3037121) Protein [Mass/volume] in Urine
101
716
1.42
2.91
3.2
3.3
g/l
0.3
0.3
0.10
45
295
(3026493) Urate [Moles/volume] in Serum or Plasma
519
5933
0.85
2.90
2.0
2.3
umol/l
1834.2
3302.9
0.80
458
5270
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
22
4.10
2.88
1.0
1.2
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
11
289
0.38
2.83
1.4
1.3
nmol/l
35.7
33.6
0.08
11
254
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2341
24172
0.87
2.82
3.6
3.8
mmol/l
5.7
5.7
2.80
2140
22579
(3006922) Hepatitis E virus Ab [Presence] in Serum
36
201
1.80
2.81
1.1
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
122
1630
0.74
2.77
1.4
1.4
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
112
819
1.38
2.72
1.2
1.3
u/ml
26.4
37.3
—
5
55
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
22
105
2.10
2.68
1.0
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
49
303
1.63
2.68
1.2
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
50
312
1.61
2.64
1.4
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2161
20781
1.13
2.62
4.5
4.1
pmol/l
14.7
14.4
4.65
1985
19414
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
18
80
2.26
2.60
1.3
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
18
80
2.26
2.60
1.3
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
38
629
0.60
2.58
1.0
1.1
u/ml
0.5
1.7
—
9
159
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
25
463
0.54
2.56
1.6
1.4
mmol/l
5.9
7.1
2.39
17
335
(3033705) Calcium.ionized [Moles/volume] in Venous blood
35
200
1.76
2.56
1.9
2.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
72
492
1.47
2.55
1.2
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
51
325
1.58
2.49
1.3
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
104
764
1.37
2.49
1.5
1.9
g/l
1.3
1.5
1.00
88
667
(1616796) Gas panel - Central venous blood
62
414
1.51
2.47
2.6
3.0
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
99
723
1.38
2.46
4.7
3.3
mmol/l
25.2
24.7
1.01
94
675
(4211845)
23
116
1.99
2.45
2.2
2.5
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
52
335
1.56
2.43
1.0
1.1
g/l
1.5
1.5
0.08
47
304
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
154
1206
1.29
2.39
1.6
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
90
650
1.40
2.39
1.8
2.1
ug/l
1.3
1.8
0.33
71
580
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
101
744
1.37
2.39
1.2
1.3
u/ml
2.8
7.9
—
8
118
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
15
64
2.35
2.38
3.1
2.3
umol/l
11.7
16.8
1.16
15
64
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
7
17
4.12
2.36
1.0
1.1
u/l
8.1
24.6
—
7
17
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
32
183
1.76
2.35
1.3
1.2
—
9.2
—
0
11
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
652
5866
1.14
2.33
1.7
1.8
mg/l
0.8
0.9
0.86
477
4351
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
86
1176
0.72
2.31
1.4
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
337
2885
1.19
2.30
1.4
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
73
512
1.44
2.30
2.2
3.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
81
1112
0.72
2.24
1.3
1.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
29
3.11
2.22
1.0
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
81
1110
0.72
2.22
1.3
1.4
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
10
36
2.78
2.20
1.2
2.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
34
552
0.61
2.19
1.0
1.1
u/ml
2.2
3.3
0.46
15
219
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1980
20550
0.90
2.18
3.4
3.5
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
6
14
4.29
2.15
1.0
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
27
462
0.58
2.14
2.2
2.6
ug/min
34.1
100.5
2.02
16
290
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
35
560
0.62
2.13
1.1
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
50
740
0.67
2.12
1.1
1.1
u/ml
1.3
1.2
0.03
15
301
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
38
237
1.61
2.07
1.8
2.1
mg/l
22.8
22.8
0.00
12
66
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
32
192
1.67
2.03
1.3
1.2
—
34.6
—
0
9
(3012501) Base excess in Blood by calculation
63
442
1.43
2.01
3.4
3.3
mmol/l
2.1
2.4
0.67
43
281
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
8
26
3.08
2.01
1.0
1.0
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
101
768
1.33
1.99
4.7
3.6
%
49.2
50.2
0.13
96
758
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
91
682
1.34
1.98
1.3
1.4
u/l
28.2
24.2
0.56
68
577
(3014271) Vancomycin [Susceptibility]
15
70
2.15
1.98
2.5
2.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
275
2348
1.19
1.97
1.2
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
510
4568
1.14
1.95
2.5
2.8
ng/l
651.5
898.8
2.23
426
3753
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
43
281
1.54
1.95
1.3
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
12
51
2.36
1.95
1.3
12.0
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
386
3392
1.16
1.94
2.0
2.3
umol/l
14.1
14.2
0.11
354
3144
(3025468) Yersinia sp identified in Specimen by Organism specific culture
43
282
1.53
1.92
1.3
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
87
1149
0.75
1.91
1.3
1.5
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
199
1653
1.22
1.91
4.5
3.6
kpa
5.9
5.9
0.35
190
1599
(4035726)
156
1914
0.81
1.91
1.3
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
680
6211
1.12
1.90
1.6
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
43
283
1.53
1.89
1.3
1.4
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
7
22
3.19
1.88
1.0
1.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
90
1179
0.76
1.88
1.8
2.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
43
284
1.52
1.87
1.3
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
114
1.85
1.87
1.3
1.6
—
—
—
0
0
(4268621)
47
317
1.49
1.85
2.0
2.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
43
285
1.52
1.84
1.3
1.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
163
1332
1.24
1.84
4.7
2.9
kpa
5.0
4.7
0.82
154
1282
(3011325) HIV 1+2 Ab [Presence] in Serum
6
17
3.53
1.83
1.2
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
197
1643
1.21
1.83
4.5
3.6
mmol/l
2.4
1.9
1.34
169
1324
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
67
485
1.39
1.83
1.1
1.2
u/ml
2.1
3.6
0.99
18
160
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
100
771
1.31
1.82
2.3
2.0
iu/l
7.7
4.2
1.52
42
300
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
267
2292
1.18
1.81
2.2
2.4
u/l
35.6
58.9
0.55
221
1972
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
40
262
1.53
1.81
1.2
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
113
887
1.28
1.80
1.3
1.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
44
642
0.68
1.78
1.0
1.1
u/ml
0.1
1.2
—
9
277
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
21
116
1.82
1.78
2.9
2.5
umol/l
60.0
51.1
0.72
21
97
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
43
288
1.50
1.77
1.3
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
55
388
1.43
1.75
1.4
1.6
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
85
646
1.32
1.72
1.2
1.2
u/ml
45.9
36.9
0.21
11
61
(3015235) Bicarbonate [Moles/volume] in Capillary blood
61
440
1.39
1.72
2.7
2.9
mmol/l
24.8
24.8
0.01
55
396
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
5
13
3.85
1.71
1.2
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
97
752
1.30
1.71
1.2
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
46
0.00
1.70
0.0
7.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
25
148
1.69
1.70
1.3
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
65
475
1.38
1.70
1.1
1.2
u/ml
2.3
4.5
2.30
22
196
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
116
1448
0.79
1.68
1.4
1.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
11
227
0.48
1.66
1.0
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
29
180
1.62
1.66
1.1
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
153
1849
0.82
1.65
3.9
4.1
ug/l
4.3
34.6
0.98
120
1426
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
107
1342
0.79
1.63
1.3
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1105
11692
0.91
1.62
3.9
3.8
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
348
3080
1.15
1.61
2.0
2.3
g/l
2.5
2.4
1.04
317
2858
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
24
143
1.68
1.61
1.3
1.6
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
48
674
0.71
1.60
1.4
1.4
nmol/l
0.4
0.4
0.01
37
546
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
107
1337
0.79
1.58
1.3
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
48
671
0.71
1.57
1.0
1.1
u/ml
5.5
5.5
0.00
23
362
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
21
122
1.73
1.54
1.5
1.3
u/ml
17.0
17.2
—
7
21
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
108
1343
0.80
1.54
1.3
1.4
—
—
—
0
0
(3010421) pH of Blood
71
536
1.33
1.54
3.4
3.3
ph
7.4
7.4
0.20
61
436
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
108
1342
0.80
1.53
1.3
1.4
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
18
100
1.80
1.53
1.2
1.1
g/l
—
0.1
—
0
5
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
11
219
0.50
1.52
1.0
1.2
u/ml
0.0
0.6
—
5
77
(3023430) Cat dander IgE Ab [Units/volume] in Serum
35
512
0.68
1.48
1.0
1.1
u/ml
2.9
3.4
0.12
11
213
(3028679) Herpes simplex virus Ab [Presence] in Serum
28
178
1.58
1.48
1.1
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
296
2610
1.15
1.46
3.6
3.8
%
31.1
31.8
0.55
223
1896
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
26
163
1.60
1.46
1.1
1.5
u/l
5.7
5.9
0.10
21
138
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
66
498
1.33
1.45
1.2
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
330
3701
0.88
1.45
1.7
1.8
%
1.5
1.4
1.32
304
3328
(3021901) Oxygen saturation in Capillary blood
43
302
1.43
1.44
2.5
2.5
—
—
—
0
0
(4094501)
41
578
0.71
1.43
1.1
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
26
164
1.59
1.43
1.6
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
707
6573
1.10
1.40
1.3
1.3
u/ml
1.1
1.5
0.58
164
1884
(3003458) Phosphate [Moles/volume] in Serum or Plasma
288
2546
1.14
1.38
3.8
5.8
mmol/l
1.0
1.0
1.96
260
2381
(3023323) Follitropin [Units/volume] in Serum or Plasma
193
2240
0.85
1.37
1.3
1.3
iu/l
30.6
26.9
0.75
175
1941
(3020779) Urea [Moles/volume] in Serum or Plasma
186
1593
1.18
1.36
5.0
8.0
mmol/l
6.4
8.1
5.75
179
1530
(3032352) Blasts [#/volume] in Cerebral spinal fluid
5
17
2.94
1.36
1.2
3.7
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
17
2.94
1.36
2.0
2.1
—
—
—
0
0
(3017704) Immunofixation for Urine
15
82
1.83
1.35
2.5
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
77
602
1.29
1.33
1.7
1.6
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
97
781
1.25
1.33
2.1
2.4
%
152.7
172.7
1.78
92
742
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
283
2508
1.14
1.32
6.0
5.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
24
152
1.58
1.31
2.2
2.2
%
13.4
11.2
1.90
24
152
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
48
351
1.37
1.31
1.6
1.6
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
41
0.00
1.31
0.0
7.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
31
209
1.49
1.30
1.6
2.8
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
5
18
2.78
1.28
1.0
1.2
—
—
—
0
0
(3036489) Thrombin time
118
975
1.22
1.28
1.7
2.0
s
20.4
20.8
0.57
108
824
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
30
202
1.49
1.27
1.4
1.5
umol/l
12.5
11.0
0.51
30
187
(3032057) Clostridioides difficile [Presence] in Stool
8
35
2.29
1.26
2.1
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
131
1559
0.83
1.26
2.4
2.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
459
5006
0.90
1.26
1.2
1.3
iu/ml
14.8
25.3
3.46
105
1534
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
34
482
0.70
1.26
2.2
2.6
nmol/l
0.9
0.8
0.17
25
417
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
17
100
1.70
1.23
1.4
1.6
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
19
2.63
1.21
1.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
27
180
1.50
1.20
2.6
2.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
51
383
1.34
1.20
2.3
2.3
%
17.2
16.7
0.39
27
185
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
30
205
1.47
1.19
1.2
1.6
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
49
648
0.75
1.19
3.1
3.6
u/ml
706.3
2079.9
0.38
42
549
(3027008) Opiates [Presence] in Urine
133
1569
0.84
1.18
2.4
2.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
19
117
1.63
1.18
1.3
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
343
3103
1.12
1.17
2.0
2.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
33
231
1.43
1.17
1.2
1.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
312
2809
1.12
1.16
2.0
2.4
%
23.6
23.8
0.11
254
2433
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
129
0.46
1.16
1.0
1.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
172
1487
1.17
1.15
2.7
3.7
ng/l
65.0
79.5
2.78
147
1334
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
8
39
2.05
1.15
1.1
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
28
403
0.69
1.14
2.7
2.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
134
1574
0.84
1.14
2.4
2.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
8
152
0.53
1.14
1.6
1.6
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
36
0.00
1.14
0.0
6.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
8
154
0.52
1.13
1.3
1.3
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
12
65
1.85
1.13
1.3
1.1
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
17
103
1.65
1.12
1.2
1.2
%
85.6
94.3
—
5
42
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
582
6240
0.92
1.12
1.5
1.6
mmol/l
1.4
1.4
0.04
478
5399
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
612
5712
1.09
1.12
2.1
2.1
mg/l
2.8
2.8
0.03
522
4923
(3001893) Eosinophils/100 leukocytes in Pleural fluid
8
40
2.00
1.12
1.0
1.5
%
1.5
3.0
—
8
35
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
222
1962
1.14
1.11
2.3
2.3
g/l
0.2
0.2
0.69
212
1853
(3023199) Leukocytes [#/volume] in Pleural fluid
22
143
1.54
1.11
1.4
1.4
e6/l
1510.3
3290.9
0.94
15
95
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
65
512
1.28
1.11
1.5
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
61
477
1.28
1.10
1.2
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
132
1545
0.85
1.09
2.4
2.0
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
41
304
1.35
1.07
1.4
1.5
mu/l
21.5
47.8
2.34
35
276
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
26
373
0.69
1.06
1.3
1.3
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
7
33
2.12
1.05
1.0
2.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
14
82
1.71
1.05
1.8
2.8
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
6
123
0.49
1.05
1.2
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
14
228
0.61
1.03
1.0
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
412
3792
1.10
1.03
3.5
4.0
ug/l
1.6
1.9
1.74
374
3460
(3028308) Erythrocytes [#/volume] in Pleural fluid
20
130
1.54
1.02
1.4
1.5
e6/l
2179.1
78982.0
—
10
72
(3014111) Lactate [Moles/volume] in Serum or Plasma
186
1636
1.15
1.02
7.4
7.0
mmol/l
1.2
1.3
1.18
177
1578
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
18
274
0.65
1.00
1.7
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
61
485
1.26
0.99
1.3
1.6
—
—
—
0
0
(3004451) EKG impression Narrative
13
76
1.71
0.98
1.1
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
31
223
1.39
0.98
1.3
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
31
223
1.39
0.98
1.3
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
31
223
1.39
0.98
1.3
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
23
2.18
0.98
2.0
1.9
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
29
0.00
0.97
0.0
2.1
—
58.7
—
0
24
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
30
0.00
0.97
0.0
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
64
792
0.80
0.96
1.1
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
16
100
1.60
0.96
1.4
1.6
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
31
0.00
0.96
0.0
8.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
23
328
0.70
0.93
1.3
1.5
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
23
158
1.46
0.93
3.9
1.8
u/field
2.5
2.0
—
10
82
(3044009) aPTT.lupus sensitive (LA screen)
6
27
2.22
0.93
1.7
1.2
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
17
109
1.56
0.93
1.2
1.1
%
79.4
92.8
—
5
45
(3045683) HLA typing for celiac disease panel - Blood or Tissue
13
209
0.62
0.93
1.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
33
243
1.36
0.92
1.3
1.4
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
57
454
1.26
0.92
3.6
3.4
mg/l
33.8
66.5
1.09
48
363
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
57
454
1.26
0.92
3.5
3.4
mg/l
24.9
33.4
0.83
48
364
(3021788) Differential panel - Synovial fluid
29
396
0.73
0.92
1.5
1.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
10
55
1.82
0.92
2.7
4.5
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
32
430
0.74
0.92
1.1
1.1
iu/ml
6.1
19512.7
—
8
120
(3032773) Endomysium IgG Ab [Titer] in Serum
34
253
1.35
0.90
1.1
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
102
867
1.18
0.89
1.2
1.1
u/ml
1.2
3.6
1.84
11
137
(4281824)
18
266
0.67
0.89
1.1
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
104
0.48
0.89
1.2
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
152
0.59
0.88
1.2
1.7
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
26
358
0.72
0.88
1.5
1.6
mmol/l
7.5
7.5
0.02
17
222
(3024928) Oxygen saturation in Venous blood
49
387
1.27
0.86
7.7
2.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
66
802
0.82
0.86
1.1
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
396
3676
1.09
0.85
2.4
2.7
mmol/l
2.4
2.4
0.09
331
3228
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
30
222
1.35
0.83
1.3
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
30
222
1.35
0.83
1.3
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
30
222
1.35
0.83
1.3
1.2
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
6
115
0.52
0.82
49.8
35.1
ug/l
7.9
7.5
—
6
104
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
16
237
0.67
0.81
1.3
1.4
g/l
0.8
1.0
1.41
16
237
(3014765) Yersinia sp identified in Stool by Organism specific culture
66
796
0.83
0.81
1.1
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
37
285
1.30
0.80
1.4
1.4
pmol/l
275.4
322.8
0.34
26
221
(3010937) Rubella virus Ab [Presence] in Serum
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
2.6
—
1.6
—
0
17
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
629
6627
0.94
0.78
1.6
1.6
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
98
0.51
0.78
1.6
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
46
367
1.26
0.77
1.5
1.3
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
14
210
0.67
0.77
1.4
1.3
—
1.6
—
0
12
(3021387) Prolactin [Units/volume] in Serum or Plasma
131
1484
0.88
0.76
1.7
1.6
mu/l
330.1
297.2
0.44
117
1321
(3018001) Oat IgE Ab [Units/volume] in Serum
0
28
0.00
0.76
0.0
1.0
—
0.2
—
0
11
(3002173) Hemoglobin [Mass/volume] in Arterial blood
189
1703
1.12
0.76
6.6
8.9
g/l
125.1
122.8
0.97
179
1640
(3003396) Base excess in Arterial blood by calculation
225
2047
1.11
0.76
6.1
8.0
mmol/l
1.2
1.0
0.42
170
1586
(3016879) Cocaine [Presence] in Urine
127
1440
0.88
0.75
2.4
2.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
37
289
1.28
0.74
1.5
1.5
—
—
—
0
0
(4146454)
11
172
0.64
0.73
2.0
2.8
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
25
2.00
0.72
1.2
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
18
125
1.44
0.72
1.2
1.5
—
—
—
0
0
(4015189)
7
39
1.80
0.72
1.1
3.0
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
212
1929
1.11
0.72
3.5
3.4
pmol/l
4.5
4.6
0.60
184
1737
(3039443) Prostate specific Ag panel - Serum or Plasma
25
333
0.75
0.71
1.6
1.6
—
—
—
0
0
(3035880) pH of Pleural fluid
11
68
1.62
0.71
1.2
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
40
1.75
0.71
1.4
2.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
58
1.55
0.69
1.8
2.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
58
1.55
0.69
1.8
2.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
128
1134
1.13
0.69
3.8
5.7
—
—
—
0
0
(3019977) pH of Arterial blood
14
93
1.51
0.69
1.9
3.3
ph
7.4
7.4
—
5
27
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
12
181
0.66
0.69
1.3
1.5
mmol/l
5.6
5.5
0.11
12
174
(3000285) Sodium [Moles/volume] in Blood
5
27
1.85
0.68
1.2
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
11
168
0.65
0.67
1.4
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
67
567
1.19
0.66
2.0
1.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
51
615
0.83
0.66
1.2
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
5
28
1.79
0.66
1.0
1.9
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
13
86
1.51
0.66
1.2
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
13
86
1.51
0.66
3.7
3.4
—
—
—
0
0
(3019174) dRVVT (LA screen)
5
29
1.73
0.64
1.6
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
266
2467
1.09
0.63
2.0
2.1
nmol/l
350.9
372.3
1.14
241
2285
(4198724)
21
155
1.36
0.63
1.2
1.7
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
12
79
1.52
0.62
1.3
1.2
u/l
12.3
11.2
0.15
12
73
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
108
955
1.14
0.62
7.2
10.8
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
12
176
0.68
0.61
1.4
1.9
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
197
1806
1.10
0.61
6.2
8.5
%
95.8
96.0
0.17
192
1742
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
293
3137
0.93
0.60
1.8
1.9
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
42
344
1.22
0.60
3.8
3.6
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
10
151
0.66
0.59
1.3
1.2
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
12
174
0.69
0.59
1.2
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
16
220
0.73
0.58
1.3
1.4
—
—
—
0
0
(44813793)
16
220
0.73
0.58
1.1
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
27
210
1.29
0.58
1.3
1.8
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
167
1829
0.91
0.58
1.9
2.3
ml/min/173m2
82.4
73.9
2.63
74
678
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
19
140
1.36
0.58
1.6
1.5
u/l
3.6
7.1
—
9
72
(3043409) Potassium [Moles/volume] in Arterial blood
64
548
1.17
0.58
3.5
4.4
mmol/l
3.8
3.8
0.23
56
512
(3027801) Oxygen [Partial pressure] in Arterial blood
222
2052
1.09
0.58
6.2
7.9
kpa
12.6
12.9
0.34
215
1964
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
222
2052
1.09
0.58
6.2
7.9
kpa
5.1
5.1
0.19
215
1962
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
113
0.62
0.58
1.3
1.1
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
15
106
1.42
0.57
1.0
1.1
—
3.9
—
0
8
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
11
73
1.51
0.56
1.1
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
12
82
1.47
0.54
3.0
2.3
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
26
204
1.28
0.54
1.0
1.1
nmol/l
407.2
398.6
0.07
21
193
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
36
295
1.22
0.52
1.3
1.3
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
25
196
1.28
0.52
1.3
1.3
titre
70.0
227.8
—
6
40
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
28
223
1.26
0.52
1.2
1.2
u/l
47.0
60.9
0.84
18
149
(3009542) Hematocrit [Volume Fraction] of Blood
2465
24890
0.95
0.52
18.7
11.9
%
40.0
40.2
0.62
1817
20029
(3048879) Bone marrow aspiration report
6
40
1.50
0.51
1.7
2.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
35
287
1.22
0.51
1.2
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
33
269
1.23
0.51
1.3
1.6
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
123
1114
1.11
0.51
6.1
8.0
mmol/l
24.5
24.5
0.01
113
1032
(3017509) Phencyclidine [Presence] in Urine
6
41
1.46
0.50
1.0
1.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
44
371
1.19
0.49
4.6
5.9
umol/l
404.1
374.5
0.57
36
325
(40768793) Breast Pathology biopsy report
57
658
0.86
0.49
1.2
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
209
2241
0.93
0.48
2.4
2.6
ug/l
0.6
0.7
3.21
140
1273
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
37
441
0.84
0.47
1.1
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
231
2163
1.07
0.47
15.4
17.0
inr
1.1
1.2
0.81
49
329
(4034850)
71
803
0.88
0.46
8.2
8.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
24
191
1.26
0.46
1.3
1.5
mmol/l
6.6
6.3
0.16
19
143
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
5
81
0.62
0.45
2.8
6.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
5
81
0.62
0.45
1.4
3.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
81
0.62
0.45
1.0
1.0
—
—
—
0
0
(3012565) Volume of 24 hour Urine
8
118
0.68
0.45
1.3
2.6
ml
1698.8
2008.5
—
8
110
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
119
0.67
0.45
1.3
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
29
237
1.23
0.45
1.0
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
163
1760
0.92
0.45
1.2
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
111
1220
0.91
0.45
2.6
2.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
40
338
1.19
0.45
1.3
1.7
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
15
198
0.76
0.45
1.3
1.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
16
121
1.32
0.44
2.8
3.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
15
197
0.76
0.44
1.3
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
75
668
1.13
0.43
2.3
2.9
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
9
127
0.71
0.43
1.6
2.3
ug/l
29.0
263.8
—
9
115
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
8
56
1.43
0.42
1.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
8
56
1.43
0.42
1.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
8
56
1.43
0.42
1.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
8
56
1.43
0.42
1.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
8
56
1.43
0.42
1.0
1.2
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
125
1148
1.09
0.42
7.6
9.4
%
0.7
0.7
0.10
125
1141
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
471
4525
1.05
0.42
1.9
2.0
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
18
140
1.29
0.42
1.2
1.4
mmol/l
5.3
6.4
1.10
18
126
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
36
424
0.85
0.41
2.9
2.6
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
14
184
0.76
0.41
2.1
2.8
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
16
0.00
0.41
0.0
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
414
4318
0.95
0.41
1.5
1.7
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
16
123
1.30
0.40
1.4
1.5
nmol/l
138.7
132.8
0.12
16
123
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.9
—
46.6
—
0
18
(3023183) Ammonium ion [Moles/volume] in Plasma
49
427
1.15
0.40
2.4
3.2
umol/l
30.2
35.2
1.83
40
373
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
27
324
0.83
0.39
1.3
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
49
559
0.87
0.39
2.0
1.8
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
36
1.39
0.38
1.0
1.0
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
26
312
0.83
0.38
3.4
4.5
u/ml
18.2
74.4
—
7
90
(3051387) C reactive protein [Mass/volume] in Capillary blood
53
467
1.14
0.38
6.2
3.3
mg/l
24.2
23.2
0.05
29
294
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
54
610
0.88
0.37
1.1
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
92
1007
0.91
0.37
1.2
1.3
u/l
12.6
10.6
0.66
75
843
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
20
161
1.24
0.37
1.0
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
17
134
1.27
0.37
1.4
1.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
41
471
0.87
0.36
1.1
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
23
189
1.22
0.36
2.6
2.5
—
—
—
0
0
(3044889) 12 lead EKG panel
1659
16363
1.03
0.35
3.1
3.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
24
199
1.21
0.35
1.2
2.1
—
—
—
0
0
(4306422)
43
490
0.88
0.35
1.1
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
28
236
1.19
0.34
1.1
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
230
2421
0.95
0.34
1.7
1.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
163
1532
1.07
0.33
8.7
8.3
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
50
562
0.89
0.33
1.7
2.1
umol/l
3.9
4.7
0.60
37
404
(3048689) Calprotectin [Mass/mass] in Stool
381
3668
1.04
0.33
2.0
2.4
ug/g
133.0
105.1
0.53
273
2919
(3024471) HLA-A [Type]
6
88
0.68
0.33
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
88
0.68
0.33
1.0
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
88
0.68
0.33
5.2
4.9
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
35
303
1.16
0.33
1.3
1.3
—
34.0
—
0
6
(3017446) Testosterone [Moles/volume] in Serum or Plasma
153
1437
1.07
0.32
1.7
2.1
nmol/l
12.3
12.1
0.08
140
1287
(3020874) Milk IgE Ab [Units/volume] in Serum
18
220
0.82
0.32
1.1
1.0
u/ml
0.3
2.8
—
5
67
(40768800) Prostate Pathology biopsy report
16
198
0.81
0.32
1.2
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
173
1633
1.06
0.32
1.1
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
43
485
0.88
0.31
1.3
1.7
e6/l
5468.6
10550.9
1.71
30
356
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
7
53
1.32
0.30
1.0
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
320
3326
0.96
0.30
1.2
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
23
271
0.85
0.29
1.1
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
59
535
1.10
0.29
1.2
1.4
u/ml
169.8
113.4
0.40
13
120
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
60
659
0.91
0.28
1.8
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
256
2669
0.96
0.28
1.3
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
39
346
1.13
0.27
1.4
1.2
—
—
—
0
0
(3020891) Body temperature
77
710
1.09
0.27
5.1
4.8
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
21
177
1.19
0.27
1.2
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
9
120
0.75
0.27
1.1
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
46
509
0.90
0.25
8.4
3.6
u/ml
0.4
0.4
0.44
26
282
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
24
207
1.16
0.25
1.2
1.1
ratio
1.1
1.0
—
9
78
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
557
5704
0.97
0.24
2.1
2.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
13
105
1.24
0.24
1.5
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
13
105
1.24
0.24
1.5
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
13
105
1.24
0.24
1.5
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
13
105
1.24
0.24
1.5
1.7
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
122
1152
1.06
0.24
7.4
9.3
%
1.5
1.4
0.33
122
1146
(3044242) Glucose [Moles/volume] in Arterial blood
12
96
1.25
0.24
1.7
2.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
24
208
1.16
0.24
1.0
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
62
573
1.08
0.22
1.2
1.4
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
7
95
0.74
0.22
1.9
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
27
238
1.14
0.22
2.5
2.5
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
5
41
1.22
0.22
1.4
2.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
520
5084
1.03
0.22
2.0
2.1
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
361.1
—
0
11
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035611) Eosinophils/100 leukocytes in Synovial fluid
0
11
0.00
0.21
0.0
2.0
—
0.1
—
0
6
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
10
0.00
0.21
0.0
2.9
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013862) HLA-DP [Type]
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
102
1079
0.94
0.21
2.9
2.9
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.7
—
177.3
—
0
12
(3024263) Appearance of Synovial fluid
8
101
0.79
0.21
1.3
2.3
—
—
—
0
0
(3013762) Body weight Measured
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(40758358) Immune stain study
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
0
13
0.00
0.21
0.0
11.0
—
126.1
—
0
8
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3001729) Color of Synovial fluid
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1065
10511
1.02
0.20
2.0
2.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
54
499
1.08
0.20
1.2
1.0
u/ml
1.0
2.6
3.61
20
266
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
14
0.00
0.20
0.0
1.1
—
8.2
—
0
14
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
6
48
1.25
0.20
1.5
1.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
49
1.22
0.20
1.7
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
9
112
0.80
0.20
1.0
1.0
—
—
—
0
0
(3036603) Volume of Urine
18
155
1.16
0.19
2.6
1.4
ml
1913.5
2181.1
—
6
28
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
16
185
0.86
0.18
1.6
1.5
%
29.6
35.3
0.30
11
109
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
11
91
1.21
0.17
1.2
1.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
11
91
1.21
0.17
1.2
1.8
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
67
0.75
0.17
1.2
1.7
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
157
1627
0.96
0.16
1.8
2.7
u/ml
26.4
44.0
1.87
151
1573
(21494890) Protein electrophoresis panel - 24 hour Urine
18
158
1.14
0.16
2.9
2.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
6
76
0.79
0.15
2.8
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
308
3010
1.03
0.15
3.3
3.5
%
21.3
21.1
0.07
121
1184
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
51
544
0.94
0.15
1.2
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
244
2378
1.03
0.14
1.3
1.2
iu/ml
177.1
159.8
0.25
102
911
(3025018) Bordetella pertussis Ab [Titer] in Serum
15
171
0.88
0.14
1.2
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
133
1283
1.04
0.14
2.2
2.9
ng/l
97.7
138.6
1.59
112
1143
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
20
179
1.12
0.14
1.3
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
20
179
1.12
0.14
1.3
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
20
179
1.12
0.14
1.3
1.5
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
14
122
1.15
0.13
1.2
3.0
umol/l
364.8
144.6
—
5
69
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
21
189
1.11
0.13
1.1
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
137
1416
0.97
0.13
2.0
2.1
ug/l
5.5
7.1
1.01
116
1257
(3002256) Pathology report gross observation
314
3203
0.98
0.13
1.3
1.2
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
29
267
1.09
0.13
1.2
1.4
mmol/l
9.9
12.5
—
9
52
(3048929) Epstein Barr virus Ab [Presence] in Serum
99
1029
0.96
0.13
1.2
1.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
24
219
1.10
0.12
1.3
1.5
mosm/kgh2o
281.5
281.4
0.01
15
178
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
106
1099
0.96
0.12
1.7
1.7
—
—
—
0
0
(3000012) Reticulocyte production index
11
95
1.16
0.11
1.5
1.6
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
29
269
1.08
0.11
1.3
1.4
mmol/l
60.7
66.3
0.33
21
226
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
37
347
1.07
0.11
1.4
1.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
24
260
0.92
0.11
1.5
1.6
%
48.0
58.1
0.58
17
167
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
51
485
1.05
0.10
1.0
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
23
212
1.09
0.10
3.5
2.2
pg
32.7
32.2
0.29
23
212
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
10
114
0.88
0.09
1.0
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
158
1616
0.98
0.09
1.2
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
44
419
1.05
0.09
2.4
2.2
g/l
131.3
131.2
0.01
38
308
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
143
1397
1.02
0.09
1.5
1.5
—
—
—
0
0
(44790048)
26
243
1.07
0.08
1.2
1.6
—
—
—
0
0
(44790047)
26
243
1.07
0.08
1.2
1.6
—
—
—
0
0
(44790049)
26
243
1.07
0.08
1.2
1.6
—
—
—
0
0
(44806118)
26
243
1.07
0.08
1.2
1.6
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
49
470
1.04
0.08
1.6
1.8
pmol/l
224.9
195.5
0.86
44
439
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
72
0.83
0.07
1.7
1.6
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
61
589
1.04
0.07
4.3
7.4
mmol/l
1.2
1.2
0.24
52
511
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
8
76
1.05
0.07
1.1
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
8
76
1.05
0.07
3.3
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
60
621
0.97
0.07
1.5
1.4
ug/g
278.1
303.5
0.37
30
317
(3017569) Oxygen content in Arterial blood
7
83
0.84
0.07
1.7
2.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
84
1.07
0.07
1.7
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
84
1.07
0.07
1.7
1.8
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
85
1.06
0.07
1.7
1.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
17
157
1.08
0.07
1.6
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
12
109
1.10
0.06
1.3
1.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
15
161
0.93
0.05
1.9
1.9
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
15
161
0.93
0.05
3.5
3.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
98
999
0.98
0.05
1.8
1.7
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
202
1997
1.01
0.04
1.2
1.3
u/ml
141.5
180.9
0.45
183
1851
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
140
1381
1.01
0.04
1.4
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
16
150
1.07
0.04
1.1
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
39
378
1.03
0.04
1.3
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
19
200
0.95
0.03
1.3
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
25
240
1.04
0.03
1.1
1.1
—
—
—
0
0
(4010399)
162
1607
1.01
0.02
1.4
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1264
12620
1.00
0.02
2.8
2.9
ug/l
102.8
89.4
1.18
1187
11922
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
60
591
1.02
0.02
1.2
1.2
u/ml
244.5
262.7
0.21
33
384
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
63
621
1.01
0.02
1.2
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
106
1050
1.01
0.02
2.5
2.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
54
532
1.02
0.01
1.1
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
763
7619
1.00
0.01
2.2
2.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
47
477
0.99
0.01
1.0
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
21
204
1.03
0.00
2.0
1.7
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
11
105
1.05
0.00
1.4
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
10
101
0.99
0.00
1.3
1.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
20
195
1.03
0.00
1.4
1.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
88
875
1.01
0.00
5.7
3.7
mmol/l
24.8
24.3
1.17
80
792
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
14
144
0.97
0.00
1.1
1.9
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
21
214
0.98
0.00
1.3
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
10
102
0.98
0.00
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
58
584
0.99
0.00
1.1
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
29
288
1.01
0.00
1.1
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
58
583
0.99
0.00
1.1
1.1
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
10
97
1.03
0.00
1.0
1.1
u/ml
0.0
4.3
—
5
50
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
18
177
1.02
0.00
5.4
7.1
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
0
9
0.00
0.00
0.0
2.8
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
21.6
—
0
9
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
6
60
1.00
0.00
1.0
1.1
ug/l
75.6
73.9
—
6
51
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
9
0.00
0.00
0.0
5.2
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
9.2
—
0
9
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
1.0
—
34.5
—
0
9
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
8
88
0.91
0.00
1.5
1.2
—
—
—
0
0
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
5
0.00
0.00
0.0
1.2
—
40.1
—
0
5
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
29.5
—
0
8
(4133840)
7
74
0.95
0.00
1.1
1.2
—
—
—
0
0
(3038385) Creatinine [Moles/volume] in Peritoneal fluid
0
7
0.00
0.00
0.0
1.1
—
167.6
—
0
7
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022670) pH of Venous cord blood
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
6
0.00
0.00
0.0
1.2
—
66.1
—
0
6
(3002079) Sodium [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.1
—
122.4
—
0
8
(3027859) Formaldehyde IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
53
0.94
0.00
1.0
1.2
—
—
—
0
0
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.7
—
2.7
—
0
7
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
77
0.91
0.00
1.0
1.1
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
8
0.00
0.00
0.0
1.0
—
1140.3
—
0
8
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
5.8
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017400) Magnesium [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
2.5
—
0
6
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
49
1.02
0.00
1.0
1.3
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
2.6
—
0
6
(3020911) Cortisol [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
97.4
—
0
5
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
10.8
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_MS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_MS | 1.952 [1.74, 2.19] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.613 |
During the follow-up period (1.1.1998 — 31.12.2019), 690 out of 8943 females with G6_MS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_MS | 1.862 [1.65, 2.1] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.015 |
During the follow-up period (1.1.1998 — 31.12.2019), 583 out of 4008 males with G6_MS died.
Mortality risk
Mortality risk for people of age
years, who have G6_MS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.221% | 0.428% |
| 5 | 1.32% | 2.309% |
| 10 | 3.478% | 5.606% |
| 15 | 6.353% | 10.683% |
| 20 | 10.966% | 17.637% |
Relationships between endpoints
↥Index endpoint: G6_MS – MS-disease / Multiple Sclerosis
GWS hits: 14
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data